# Progress Note 03 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charlotte Brontë (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI025-SYN
- Date: 2026-01-29
- Fictional facility: St. Posthumous Health Center
- Fictional author: Eleanor Thwaite, MD
- Calendar frame: modern shifted

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient, with direct admission to the antenatal ward

## Chief complaint

Vomiting everything for a day and a half, dizzy when she stands, and passing little urine. **S**

## History of present illness

Ms. Brontë is a 38-year-old woman in her first pregnancy, at 9 weeks 3 days by a 7-week dating scan, with moderate nausea and vomiting of pregnancy treated for two weeks with doxylamine-pyridoxine, raised nine days ago to four tablets a day, and metoclopramide 10 mg three times a day added at the same visit. She was a little better for two days and then worse. For the last 36 hours she has kept down neither fluids nor tablets and has vomited eight to ten times a day, including bile. She feels faint when she stands, her mouth is dry, and she has passed a small amount of dark urine twice today. She has had no abdominal pain, fever, diarrhea, headache, visual change, confusion, unsteadiness, palpitations, or tremor, and no vaginal bleeding. Metoclopramide has caused no restlessness or abnormal movements. She weighs 42.6 kg, 7.4 percent below her pre-pregnancy weight of 46.0 kg. Her PUQE-24 score today is 14 (severe). A family member drove her in. **S**

| Element | Detail |
|---|---|
| Onset | Nausea and vomiting from about 6 weeks; unable to keep fluids down for 36 hours |
| Severity | PUQE-24 score 14 (severe); vomiting eight to ten times a day |
| Associated signs and symptoms | Faint on standing, dry mouth, little dark urine |
| Pertinent negatives | No pain, fever, diarrhea, bleeding, headache, confusion, unsteadiness, or visual change |
| Treatment so far | Doxylamine-pyridoxine four tablets a day and metoclopramide 10 mg three times a day; tablets now vomited |
| Weight | 42.6 kg, 7.4 percent below her pre-pregnancy weight |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Weak and lightheaded on standing; no fever |
| Gastrointestinal | Positive | Vomiting eight to ten times a day; no abdominal pain, diarrhea, or blood in the vomit |
| Genitourinary | Positive | Small amounts of dark urine; no burning or frequency; no vaginal bleeding |
| Neurological | Negative | No headache, confusion, double vision, or unsteadiness |
| Endocrine | Negative | No palpitations, tremor, or heat intolerance |
| Psychiatric | Positive | Low and frightened by how ill she feels; no thoughts of self-harm |

6 systems reviewed. **S**

## Current medications

- Folic acid 0.4 mg oral tablet, one tablet by mouth daily (replacing an iron-containing prenatal vitamin while nausea is severe) **S**
- Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, one tablet in the morning, one mid-afternoon, and two at bedtime (four a day) **S**
- Sodium chloride 0.9% with potassium chloride 20 mmol per liter, 1000 mL intravenously over 8 hours **S**
- Thiamine 100 mg intravenously daily, the first dose before any dextrose **S**
- Ondansetron 4 mg intravenously every 8 hours **S**
- Enoxaparin 20 mg subcutaneously once daily during the admission (weight under 50 kg) **S**

## Allergies

- No known allergy **S**

## Objective

BP 96/60 mmHg; pulse 108 bpm; respirations 16/min; temperature 36.9 °C; oxygen saturation 99% on room air; weight 42.6 kg; BMI 18.4 kg/m². All vital signs are synthetic.

Hemoglobin: 14.1 g/dL; Sodium: 133 mmol/L (low); Potassium: 3.1 mmol/L (low); Chloride: 94 mmol/L (low); Bicarbonate (total CO2): 31 mmol/L (high); BUN: 21 mg/dL (high); Creatinine: 0.71 mg/dL; Glucose: 68 mg/dL (low); Magnesium: 1.6 mg/dL (low); Phosphate: 2.6 mg/dL; ALT: 66 U/L (high); AST: 49 U/L (high); TSH: 0.03 mIU/L (low); Free T4: 2.1 ng/dL (high); Urine ketones: 80 mg/dL (high). All results are synthetic.

## Change since baseline

- Hemoglobin: 12.8 g/dL at baseline, 14.1 g/dL at this visit **S**
- Sodium: 137 mmol/L at baseline, 133 mmol/L (low) at this visit **S**
- Potassium: 3.9 mmol/L at baseline, 3.1 mmol/L (low) at this visit **S**
- Chloride: 102 mmol/L at baseline, 94 mmol/L (low) at this visit **S**
- Bicarbonate (total CO2): 24 mmol/L at baseline, 31 mmol/L (high) at this visit **S**
- BUN: 8 mg/dL at baseline, 21 mg/dL (high) at this visit **S**
- Creatinine: 0.52 mg/dL at baseline, 0.71 mg/dL at this visit **S**
- Glucose: 76 mg/dL at baseline, 68 mg/dL (low) at this visit **S**
- Urine ketones: 15 mg/dL (high) at baseline, 80 mg/dL (high) at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Slight, pale, and tired; retching into a bowl; alert |
| Hydration | Dry mucous membranes; capillary refill 3 seconds; blood pressure 96/60 mmHg and pulse 108 seated, 88/56 mmHg and 124 standing |
| Neck | Thyroid not enlarged; no bruit |
| Eyes | No proptosis or lid lag; no nystagmus |
| Cardiovascular | Sinus tachycardia; no murmur |
| Abdomen | Soft and non-tender; no guarding; uterus not yet palpable |
| Neurological | Oriented; normal eye movements; no ataxia; no tremor |
| Fetal | Bedside ultrasound: fetal cardiac activity present |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hyperemesis gravidarum with metabolic disturbance** (O21.1). Protracted vomiting with more than 5 percent weight loss, dehydration with orthostatic hypotension, and electrolyte disturbance (sodium 133, potassium 3.1, chloride 94, bicarbonate 31 mmol/L, urea nitrogen 21 mg/dL, magnesium 1.6 mg/dL) meet the definition of hyperemesis gravidarum; PUQE-24 score 14. Hemoglobin 14.1 g/dL, up from 12.8, and concentrated urine reflect hemoconcentration. ALT 66 and AST 49 U/L are a common, reversible rise in hyperemesis. Glucose 68 mg/dL from starvation. Urine ketones 80 mg/dL are recorded but not used to judge severity. A dating scan excluded a multiple or molar pregnancy; there is no pain, fever, diarrhea, or urinary infection to suggest another cause. No sign of Wernicke encephalopathy. She cannot take oral treatment, so outpatient care has failed. **S**
   - Admit to the antenatal ward today.
   - Thiamine 100 mg intravenously now, before any dextrose-containing fluid, then daily.
   - 0.9% sodium chloride with potassium chloride 20 mmol per liter, 1000 mL every 8 hours, adjusted to daily electrolytes; magnesium sulfate 2 g intravenously over an hour.
   - Stop metoclopramide. After counseling she agreed to ondansetron 4 mg by slow intravenous injection every 8 hours: it is effective, and the absolute increase in orofacial clefting with first-trimester use is very small and must be weighed against the risks of uncontrolled vomiting. The electrocardiogram today shows QTc 438 ms; potassium and magnesium are being replaced.
   - Restart doxylamine-pyridoxine by mouth when she can keep tablets down.
   - Refeeding precautions: small meals as nausea allows, with phosphate and magnesium checked during the admission and at the next visit.
   - Thromboprophylaxis while admitted: enoxaparin 20 mg once daily (weight under 50 kg), stopped at discharge, with the risk reassessed then.
   - Discharge when she keeps fluids, food, and tablets down; then ondansetron by mouth every 8 hours, doxylamine-pyridoxine four tablets a day, and thiamine 100 mg three times a day until she eats regular meals.
2. **Gestational transient thyrotoxicosis** (O99.281). TSH 0.03 mIU/L with free T4 2.1 ng/dL, mildly raised, in severe hyperemesis at 9 weeks, without goiter, eye signs, tremor, or a history of thyroid disease: the pattern of hCG stimulation of the thyroid, not Graves disease. **S**
   - No antithyroid drug.
   - Repeat TSH and free T4 at 16 to 18 weeks; TSH-receptor antibodies only if the abnormality persists or signs of Graves disease appear.
3. **Nausea and vomiting of pregnancy, now hyperemesis gravidarum** (O21.9). The presenting nausea and vomiting has progressed to hyperemesis gravidarum and is superseded by that diagnosis. **S**
   - Managed under hyperemesis gravidarum.
4. **First pregnancy at 38** (O09.519). Fetal cardiac activity present today. Aneuploidy screening is not affected by the admission. **S**
   - Continue folic acid when she can take tablets.
   - Cell-free DNA screening at the next visit, from 10 weeks, as she chose.

## Medication changes

- Stopped: Metoclopramide 10 mg oral tablet, one tablet by mouth three times a day before meals **S**
- Started: Sodium chloride 0.9% with potassium chloride 20 mmol per liter, 1000 mL intravenously over 8 hours **S**
- Started: Thiamine 100 mg intravenously daily, the first dose before any dextrose **S**
- Started: Ondansetron 4 mg intravenously every 8 hours **S**
- Started: Enoxaparin 20 mg subcutaneously once daily during the admission (weight under 50 kg) **S**
- Started: Magnesium sulfate 2 g in 50 mL intravenously over 1 hour, once **S**

## Guideline basis

- ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024), Royal College of Obstetricians and Gynaecologists (BJOG)
- Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium (Green-top Guideline No. 37a) (2015), Royal College of Obstetricians and Gynaecologists
- 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum (2017), American Thyroid Association (Thyroid)

## Follow-up

- Prenatal review about ten days after admission, with electrolytes repeated within a week of discharge. Return the same day if vomiting returns and she cannot keep fluids down for 24 hours, if she feels faint, or if confusion, unsteadiness, or double vision develop. **S**
- Next scheduled visit 2026-02-10: prenatal visit at 11 weeks: nausea and vomiting review and cell-free DNA screening. **S**
